Author | Ilya Petrou, M.D.


Researchers encourage reporting on hormone therapy in acne trial demographics

July 16, 2020

Many current acne clinical trials do not consider those patients already on hormone therapy, which researchers say may affect therapeutic outcomes. Authors of a recent study encourage this reporting in future studies to help clinicians better assess how the data might represent a practice population.

Injection technique aims to optimize outcomes

July 15, 2020

A novel filler injection technique may address the different facial areas and compartments as well as respect the line of ligaments for optimal lifting and volumizing effects requiring less filler product.

Immune checkpoint inhibitor therapy advances treatment for Merkel cell carcinoma

July 14, 2020

Treatment for Merkel cell carcinoma has evolved due to the high aggressiveness and metastatic rate of the tumors. Immune checkpoint inhibitor therapy may change prognosis and quality of life.

Immunotherapy implications for NMSC

July 13, 2020

The biology of nonmelanoma skin cancers and their strong immunogenicity makes these tumors good candidates for novel and emerging immunotherapeutic agents.